As for Ebola, there is absolutely no market at all, so the only reason we have two vaccines in late-stage clinical trials now, is actually because of a somewhat misguided fear.
Što se ebole tiče, ne postoji nikakvo tržište, tako da je jedini razlog što imamo dva cjepiva u stadiju kliničkih istraživanja zapravo strah u nekoj zabludi.